Patent Application
20200261861
The present embodiments are related to multi-layer polymeric membranes, including membranes comprising graphene materials for uses such as water treatment, desalination of saline water, or water removal.
Due to the increase of human population and water consumption coupled with limited freshwater resources on earth, technologies such as seawater desalination and water treatment/recycle to provide safe and fresh water have become more important to our society. The desalination process using reverse osmosis (RO) membrane is the leading technology for producing fresh water from saline water. Most of current commercial RO membranes adopt a thin-film composite (TFC) configuration consisting of a thin aromatic polyamide selective layer on top of a microporous substrate; typically a polysulfone membrane on non-woven polyester. Although these RO membranes can provide excellent salt rejection rate, higher water flux; thinner and more hydrophilic membranes are still desired to further improve energy efficiency of the RO process. Therefore, new membrane materials and synthetic methods are in high demand to achieve the desired properties as described above.
This disclosure relates to a Graphene Oxide (GO) based multilayered membrane suitable for high water flux applications. The GO membrane may comprise one or more water soluble cross-linkers. Methods of efficiently and economically making these GO membrane compositions are also described. Water can be used as a solvent in preparing these GO membrane compositions, which makes the membrane preparation process more environmentally friendly and more cost effective.
Some embodiments include a selectively permeable membrane, such as a water permeable membrane, comprising: a porous support; and a crosslinked graphene oxide composite layer in physical communication with the porous support, wherein the crosslinked graphene oxide composite layer is formed by reacting a mixture comprising a graphene oxide compound and a cross-linker, wherein the cross-linker comprises:
or a salt thereof; wherein a dashed line indicates the presence or absence of a covalent bond; R1, R2, R2a, R3, and R4 are independently H, OH, NH2, CH3, CO2H, —CO2—CnH2n+1, or SO3H, provided that OH, NH2, and SO3H do not attach directly to N, O, or —OCH2—; R5 is H, CH3, or C2H5; R6, R7, R8, and R9 are independently-(CH2)n—, —CH2CH2O(CH2)n—, phenyl, -phenyl-CH2—, or -phenyl-CH2O(CH2)n—; and each n and m are independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; k is 0 or 1. In some embodiments, the membrane has a high water flux, and is capable of salt rejection.
Some embodiments include a selectively permeable membrane, such as a water permeable membrane, comprising: a porous support; an intermediate filtering layer comprising an silica composite, in physical communication with the porous support, wherein the silica composite is formed by reacting a mixture comprising silica nanoparticles and polyvinyl alcohol; and a crosslinked graphene oxide composite layer in physical communication with said intermediate filtering layer, wherein the crosslinked graphene oxide composite layer is formed by reacting a mixture comprising a graphene oxide compound and a cross-linker, wherein the cross-linker comprises: a polyvinyl alcohol, or one of the cross-linker compounds described in the paragraph above. In some embodiments, the membrane has a high water flux, and is capable of salt rejection.
Some embodiments include a method of making a selectively permeable membrane, such as water permeable membrane, comprising: curing a coating mixture that has been applied to a substrate, wherein the curing is carried out at a temperature of 50° C. to 150° C. for 1 minute to 5 hours, wherein the coating mixture comprises an aqueous solution comprising an optionally substituted graphene oxide and a cross-linker that has been rested for 30 minutes to 12 hours to create a coating mixture.
Some embodiments include a method of removing solute from an unprocessed solution comprising exposing the unprocessed solution to a selectively permeable membrane, such as a water permeable membrane, described herein.
A selectively permeable membrane includes a membrane that is relatively permeable for a particular fluid, such as a particular liquid or gas, but impermeable for other materials, including other fluids or solutes. For example, a membrane may be relatively permeable to water or water vapor and relatively impermeable ionic compounds or heavy metals. In some embodiments, the selectively permeable membrane can be permeable to water while being relatively impermeable to salts.
As used herein, the term “fluid communication” means that a fluid can pass through a first component and travel to and through a second component or more components regardless of whether they are in physical communication or the order of arrangement.
The present disclosure relates to water separation membranes where a highly hydrophilic composite material with low organic compound permeability and high mechanical and chemical stability may be useful to support a polyamide salt rejection layer in a RO membrane. This membrane material may be suitable for solute removal from an unprocessed fluid, such as desalination from saline water, purifying drinking water, or waste water treatment. Some selectively permeable membranes described herein are GO-based membranes having a high water flux, which may improve the energy efficiency of RO membranes and improve water recovery/separation efficiency. In some embodiments, the GO-based membrane can comprise one or more filtering layers, where at least one layer can comprise a composite of a crosslinked graphene oxide (GO). It is believed that a crosslinked GO layer, with graphene oxide's potential hydrophilicity and selective permeability, may provide a membrane for broad applications where high water permeability with high selectivity of permeability is important. In some embodiments, the GO-based membrane can further comprise a filtering layer of crosslinked silica nanoparticles. It is believed that the additional layer of crosslinked silica nanoparticles may result in an increase in material strength. In addition, these selectively permeable membranes may also be prepared using water as a solvent, which can make the manufacturing process much more environmentally friendly and cost effective.
Generally, a selectively permeable membrane, such as a water permeable membrane comprises a porous support and a filtering layer. The filtering layer may be in fluid communication with the support. For example, as depicted in
In some embodiments, a filtering layer may comprise, or consist of, a crosslinked graphene oxide layer, such as a crosslinked graphene oxide composite layer. For example, in
In some embodiments, the filtering layers may comprise a plurality of crosslinked GO layers.
A silica composite layer may be present, which may act as the sole filtering layer, or may be an intermediate layer between the porous support and another filtering layer, such as a crosslinked graphene oxide layer, e.g. a crosslinked graphene oxide composite layer. For example, in
In some embodiments, the filtering layers may comprise a plurality of silica nanoparticle layers.
Additional optional filtering layers may also be, such as a salt rejection layer, and etc. In addition, the membrane can also include a protective layer. In some embodiments, the protective layer can comprise a hydrophilic polymer. In some embodiments, the fluid, such as a liquid or gas, passing through the membrane travels through all the components regardless of whether they are in physical communication or their order of arrangement.
A protective layer may be placed in any position that helps to protect the selectively permeable membrane, such as a water permeable membrane, from harsh environments, such as compounds with may deteriorate the layers, radiation, such as ultraviolet radiation, extreme temperatures, etc. Some embodiments may have a configuration depicted in
In some embodiments, the resulting membrane can allow the passage of water and/or water vapor, but resists the passage of solute. For some membranes the solute restrained can comprise ionic compounds such as salts or heavy metals.
In some embodiments, the membrane can be used to remove water from a control volume. In some embodiments, a membrane may be disposed between a first fluid reservoir and a second fluid reservoir such that the reservoirs are in fluid communication through the membrane. In some embodiments, the first reservoir may contain a feed fluid upstream and/or at the membrane.
In some embodiments, the membrane selectively allows liquid water or water vapor to pass through while keeping solute, or liquid material from passing through. In some embodiments, the fluid upstream of the membrane can comprise a solution of water and solute. In some embodiments, the fluid downstream of the membrane may contain purified water or processed fluid. In some embodiments, as a result of the layers, the membrane may provide a durable desalination system that can be selectively permeable to water, and less permeable to salts. In some embodiments, as a result of the layers, the membrane may provide a durable reverse osmosis system that may effectively filter saline water, polluted water or feed fluids.
A selectively permeable membrane, such as a water permeable membrane, may further comprise a salt rejection layer to help prevent salts from passing through the membrane.
Some non-limiting examples of a selectively permeable membrane comprising a salt rejection layer are depicted in
Some selectively permeable membranes, such as water permeable membranes, may comprise a crosslinked graphene oxide layer, such as a crosslinked graphene oxide composite layer, a silica composite layer, and a salt rejection layer.
In some embodiments, the membrane exhibits a normalized volumetric water flow rate of about 10-1000 gal·ft−2·day−1·bar−1; about 20-750 gal·ft−2·day−1·bar−1; about 100-500 gal·ft−2·day−1·bar−1; about 10-50 gal·ft−2·day−1·bar−1; about 50-100 gal·ft2·day−1·bar−1; about 10-200 gal·ft2·day−1·bar−1; about 200-400 gal·ft−2·day−1·bar−1; about 400-600 gal·ft2·day−1·bar−1; about 600-800 gal·ft−2·day−1·bar−1; about 800-1000 gal·ft−2·day−1·bar−1; at least about 10 gal·ft−2·day−1·bar−1, about 20 gal·ft−2·day−1·bar−1, about 100 gal·ft−2·day−1·bar−1, about 200 gal·ft−2·day−1·bar−1 or any normalized volumetric water flow rate in a range bounded by any combination of these values.
In some embodiments, a membrane may be a selectively permeable. In some embodiments, the membrane may be an osmosis membrane. In some embodiments, the membrane may be a water separation membrane. In some embodiments, the membrane may be a reverse osmosis (RO) membrane. In some embodiments, the selectively permeable membrane may comprise multiple layers, wherein at least one layer contains a GO-PVA-based composite.
The membranes described herein can comprise a crosslinked GO layer. Some crosslinked GO-layers can comprise a crosslinked GO composite layer. In some embodiments, the crosslinked GO layer, such as a crosslinked GO composite layer, is formed by reacting a mixture comprising a graphene oxide and a cross-linker. In some embodiments, the GO-based composite can also comprise one or more additives. In some embodiments, the GO-based composite is crosslinked wherein the constituents of the composite (e.g., graphene oxide compound, the cross-linker, and/or additives) are physically or chemically bound to any combination of each other to result in a material matrix.
In some embodiments, the crosslinked GO layer, such as a crosslinked GO composite layer, can have an interlayer distance or d-spacing of about 0.5-3 nm, about 0.6-2 nm, about 0.7-1.8 nm, about 0.8-1.7 nm, about 0.9-1.7 nm, about 1.2-2 nm, about 1.5-2.3 nm, about 1.61 nm, about 1.67 nm, about 1.55 nm or any distance in a range bounded by any of these values. The d-spacing can be determined by x-ray powder diffraction (XRD).
The crosslinked GO layer, such as a crosslinked GO composite layer, can have any suitable thickness. For example, some GO-based composite layers may have a thickness ranging from about 20 nm to about 1,000 nm, about 5-40 nm, about 10-30 nm, about 20-60 nm, about 50-100 nm, about 100-170 nm, about 170-200 nm, about 180-220 nm, about 200-250 nm, about 250-300 nm, about 300-400 nm, about 400-600 nm, about 600-800 nm, about 800-1000 nm, about 50 nm to about 500 nm, about 100 nm to about 400 nm, about 250 nm, or any thickness in a range bounded by any of these values.
In general, graphene-based materials have many attractive properties, such as a 2-dimensional sheet-like structure with extraordinary high mechanical strength and nanometer scale thickness. The graphene oxide (GO), an exfoliated oxidation of graphite, can be mass produced at low cost. With its high degree of oxidation, graphene oxide has high water permeability and also exhibits versatility to be functionalized by many functional groups, such as amines or alcohols to form various membrane structures. Unlike traditional membranes, where the water is transported through the pores of the material, in graphene oxide membranes the transportation of water can be between the interlayer spaces. GO's capillary effect can result in long water slip lengths that offer fast water transportation rate. Additionally, the membrane's selectivity and water flux can be controlled by adjusting the interlayer distance of graphene sheets, or by the utilization of different crosslinking moieties.
In the membranes disclosed, a GO material may be optionally substituted. In some embodiments, the optionally substituted graphene oxide may contain a graphene which has been chemically modified, or functionalized. A modified graphene may be any graphene material that has been chemically modified, or functionalized. In some embodiments, the graphene oxide can be optionally substituted.
Functionalized graphene includes one or more functional groups not present in graphene oxide, such as functional groups that are not OH, COOH, or an epoxide group directly attached to a C-atom of the graphene base. Examples of functional groups that may be present in functionalized graphene include halogen, alkene, alkyne, cyano, ester, amide, or amine.
In some embodiments, at least about 99%, at least about 95%, at least about 90%, at least about 80%, at least about 70%, at least about 60%, at least about 50%, at least about 40%, at least about 30%, at least about 20%, at least about 10%, or at least about 5% of the graphene molecules may be oxidized or functionalized. In some embodiments, the graphene material is graphene oxide, which may provide selective permeability for gases, fluids, and/or vapors. In some embodiments, graphene oxide can also include reduced graphene oxide. In some embodiments, the graphene oxide compound can be graphene oxide, reduced-graphene oxide, functionalized graphene oxide, or functionalized and reduced-graphene oxide.
It is believed that there may be a large number (˜30%) of epoxy groups on GO, which may be readily reactive with hydroxyl groups at elevated temperatures. It is also believed that GO sheets have an extraordinary high aspect ratio which provides a large available gas/water diffusion surface as compared to other materials, and it has the ability to decrease the effective pore diameter of any substrate supporting material to minimize contaminant infusion while retaining flux rates. It is also believed that the epoxy or hydroxyl groups increases the hydrophilicity of the materials, and thus contributes to the increase in water vapor permeability and selectivity of the membrane.
In some embodiments, the optionally substituted graphene oxide may be in the form of sheets, planes or flakes. In some embodiments, the graphene material may have a surface area of about 100-5000 m2/g, about 150-4000 m2/g, about 200-1000 m2/g, about 500-1000 m2/g, about 1000-2500 m2/g, about 2000-3000 m2/g, about 100-500 m2/g, about 400-500 m2/g, or any surface area in a range bounded by any of these values.
In some embodiments, the graphene oxide may be platelets having 1, 2, or 3 dimensions with size of each dimension independently in the nanometer to micron range. In some embodiments, the graphene may have a platelet size in any one of the dimensions, or may have a square root of the area of the largest surface of the platelet, of about 0.05-100 μm, about 0.05-50 μm, about 0.1-50 μm, about 0.5-10 μm, about 1-5 μm, about 0.1-2 μm, about 1-3 μm, about 2-4 μm, about 3-5 μm, about 4-6 μm, about 5-7 μm, about 6-8 μm, about 7-10 μm, about 10-15 μm, about 15-20 μm, about 50-100 μm, about 60-80 μm, about 50-60 μm, about 25-50 μm, or any platelet size in a range bounded by any of these values.
In some embodiments, the GO material can comprise at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% of graphene material having a molecular weight of about 5,000 Daltons to about 200,000 Daltons.
The cross-linker can comprise a compound having a nucleophilic group. It is believed that the nucleophilic group can react with an epoxide to form a covalent linkage between the nucleophilic atom of the cross-linker and one of the carbon atoms of the epoxide on the graphene oxide. In some embodiments, the cross-linker comprises polyvinyl alcohol, optionally substituted meta-phenylene diamine, optionally substituted biphenyl, optionally substituted triphenylmethane, optionally substituted diphenylamine, or optionally substituted bishydroxymethyl propanediol.
Unless otherwise indicated, when a compound or a chemical structure, for example graphene oxide, is referred to as being “optionally substituted,” it includes a compound or a chemical structure that either has no substituents (i.e., unsubstituted), or has one or more substituents (i.e., substituted). The term “substituent” has the broadest meaning known in the art, and includes a moiety that replaces one or more hydrogen atoms attached to a parent compound or structure. In some embodiments, a substituent may be any type of group that may be present on a structure of an organic compound, which may have a molecular weight (e.g., the sum of the atomic masses of the atoms of the substituent) of 15-50 g/mol, 15-100 g/mol, 15-150 g/mol, 15-200 g/mol, 15-300 g/mol, or 15-500 g/mol. In some embodiments, a substituent comprises, or consists of: 0-30, 0-20, 0-10, or 0-5 carbon atoms; and 0-30, 0-20, 0-10, or 0-5 heteroatoms, wherein each heteroatom may independently be: N, O, S, Si, F, Cl, Br, or I; provided that the substituent includes one C, N, O, S, Si, F, Cl, Br, or I atom. Examples of substituents include, but are not limited to, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, hydroxy, alkoxy, aryloxy, acyl, acyloxy, alkylcarboxylate, thiol, alkylthio, cyano, halo, thiocarbonyl, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, C-amido, N-amido, S-sulfonamido, N-sulfonamido, isocyanato, thiocyanato, isothiocyanato, nitro, silyl, sulfenyl, sulfinyl, sulfonyl, haloalkyl, haloalkoxyl, trihalomethanesulfonyl, trihalomethanesulfonamido, amino, etc.
For convenience, the term “molecular weight” is used with respect to a moiety or part of a molecule to indicate the sum of the atomic masses of the atoms in the moiety or part of a molecule, even though it may not be a complete molecule.
In some embodiments, the crosslinker may be a polyvinyl alcohol. The molecular weight of the polyvinyl alcohol (PVA) in may be about 100-1,000,000 Daltons (Da), about 10,000-500,000 Da, about 10,000-50,000 Da, about 50,000-100,000 Da, about 70,000-120,000 Da, about 80,000-130,000 Da, about 90,000-140,000 Da, about 90,000-100,000 Da, about 95,000-100,000 Da, about 89,000-98,000 Da, about 89,000 Da, about 98,000 Da, or any molecular weight in a range bounded by any of these values.
Some crosslinkers may be a compound represented by Formula 1, Formula 2, Formula 3, Formula 4, or Formula 5, or a salt of a compound represented by any of Formula 1-5.
With respect to any relevant structural representation, such as Formula 1, 2, 3, 4, or 5, R1 is H, OH, NH2, CH3, CO2H, —CO2—CnH2n+1, or SO3H, provided that (for example with respect to Formula 5) OH, NH2, and SO3H do not attach directly to N, O, or —OCH2—. Salt forms of the relevant functional groups are also included, e.g. CO2Li, CO2Na, CO2K, SO3H, SO3Li, SO3Na, or SO3K.
With respect to any relevant structural representation, such as Formula 1, 2, 3, 4, or 5, R2 is H, OH, NH2, CH3, CO2H, —CO2—CnH2n+1, or SO3H, provided that (for example with respect to Formula 5) OH, NH2, and SO3H do not attach directly to N, O, or —OCH2—. Salt forms of the relevant functional groups are also included, e.g. CO2Li, CO2Na, CO2K, SO3H, SO3Li, SO3Na, or SO3K.
With respect to any relevant structural representation, such as Formula 1, 2, 4, or 5, R3 is H, OH, NH2, CH3, CO2H, —CO2—CnH2n+1, or SO3H, provided (for example with respect to Formula 4 or 5) that OH, NH2, and SO3H do not attach directly to N, O, or —OCH2—. Salt forms of the relevant functional groups are also included, e.g. CO2Li, CO2Na, CO2K, SO3H, SO3Li, SO3Na, or SO3K.
With respect to any relevant structural representation, such as Formula 1, 2, 3, 4, or 5, R4 is H, OH, NH2, CH3, CO2H, —CO2—CnH2n+1, or SO3H, provided that provided (for example with respect to Formula 3 or 5) OH, NH2, and SO3H do not attach directly to N, O, or —OCH2—. Salt forms of the relevant functional groups are also included, e.g. CO2Li, CO2Na, CO2K, SO3H, SO3Li, SO3Na, or SO3K.
With respect to any relevant structural representation, such as Formula 4, R2a is H, OH, NH2, CH3, CO2H, —CO2—CnH2n+1, or SO3H. Salt forms of the relevant functional groups are also included, e.g. CO2Li, CO2Na, CO2K, SO3H, SO3Li, SO3Na, or SO3K.
With respect to any relevant structural representation, such as Formula 4, k is 0 or 1. In some embodiments, k is 0. In some embodiments, k is 1.
With respect to any relevant structural representation, such as Formula 4, m is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.
With respect to any relevant structural representation, such as Formula 3, 4, or 5 (e.g. in —(CH2)n—, —CH2CH2O(CH2)n—, phenyl, -phenyl-CH2—, or -phenyl-CH2O(CH2)n—), each n is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.
With respect to any relevant structural representation, such as Formula 4, a dashed line indicates the present or absence of a covalent bond. For example, Formula 4a is an example of a formula wherein the dashed line indicates a covalent bond, and Formula 4b is an example of a formula wherein the dashed line indicates absence of a covalent bond.
With respect to any relevant structural representation, such as Formula 3, R5 is H, CH3, or C2H5.
With respect to any relevant structural representation, such as Formula 5, R6 is —(CH2)n—, —CH2CH2O(CH2)n—, phenyl, -phenyl-CH2—, or -phenyl-CH2O(CH2)n—.
With respect to any relevant structural representation, such as Formula 5, R7 is —(CH2)n—, —CH2CH2O(CH2)n—, phenyl, -phenyl-CH2—, or -phenyl-CH2O(CH2)n—.
With respect to any relevant structural representation, such as Formula 5, R8 is —(CH2)n—, —CH2CH2O(CH2)n—, phenyl, -phenyl-CH2—, or -phenyl-CH2O(CH2)n—.
With respect to any relevant structural representation, such as Formula 5, R9 is —(CH2)n—, —CH2CH2O(CH2)n—, phenyl, -phenyl-CH2—, or -phenyl-CH2O(CH2)n—.
With respect to Formula 1, in some embodiments R1 is NH2. In some embodiments, R2 is NH2. In some embodiments, R3 is CO2H or a salt thereof.
With respect to Formula 2, in some embodiments R1 is OH. In some embodiments, R1 is NH2. In some embodiments, R2 is OH. In some embodiments, R2 is NH2. In some embodiments, R3 is OH. In some embodiments, R3 is CO2H or a salt thereof (e.g. CO2Na). In some embodiments, R4 is OH. In some embodiments, R4 is CO2H or a salt thereof (e.g. CO2Na).
With respect to Formula 3, in some embodiments, R1 is OH. In some embodiments, R2 is OH. In some embodiments, R4 is SO3H or a salt thereof (e.g. SO3Na). In some embodiments, R5 is CH3. In some embodiments, n is 4.
With respect to Formula 4, Formula 4a, or Formula 4b, in some embodiments R1 is NH2. In some embodiments, R2 is H. In some embodiments, R2 is NH2. In some embodiments, R2a is NH2. In some embodiments, R2a is H. In some embodiments, R3 is H. In some embodiments, R3 is SO3H or a salt thereof (e.g. SO3Na or SO3K). In some embodiments, R4 is H. In some embodiments, R4 is SO3H or a salt thereof (e.g. SO3Na or SO3K). In some embodiments, m is 0. In some embodiments, m is 3. In some embodiments, n is 0. In some embodiments, n is 3. In some embodiments, k is 0. In some embodiments, k is 1.
With respect to Formula 5, in some embodiments, R1 is OH. In some embodiments, R1 is CO2CH3. In some embodiments, R2 is SO3H or a salt thereof (e.g. SO3Na or SO3K). In some embodiments, R2 is CO2CH3. In some embodiments, R2 is OH. In some embodiments, R3 is OH. In some embodiments, R3 is CO2CH3. In some embodiments, R4 is OH. In some embodiments, R4 is CO2CH3. In some embodiments, R4 is SO3H or a salt thereof (e.g. SO3Na or SO3K). In some embodiments, R6 is —CH2CH2—. In some embodiments, R6 is phenyl. In some embodiments, R6 is -phenyl-CH2—. In some embodiments, R7 is —CH2CH2CH2CH2—. In some embodiments, R7 is phenyl. In some embodiments, R7 is -phenyl-CH2—. In some embodiments, R8 is —CH2CH2—. In some embodiments, R8 is phenyl. In some embodiments, R8 is -phenyl-CH2—. In some embodiments, R9 is —CH2CH2—. In some embodiments, R9 is phenyl. In some embodiments, R9 is -phenyl-CH2OCH2CH2CH2CH2—.
In some embodiments, the crosslinker is, or comprises:
[CLC-2.1, or benzene-1,3-diamine], or a salt thereof. In some embodiments, the crosslinker is optionally substituted benzene-1,3-diamine, or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-2.2, or 3,5-diaminobenzoic acid], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 3,5-diaminobenzoic acid, or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-3.1 or 2,2′-diamino-[1,1′-biphenyl]-4,4′-diol], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 2,2′-diamino-[1,1′-biphenyl]-4,4′-diol, or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-3.2 or sodium 4,4′-dihydroxy-[1,1′-biphenyl]-2,2′-dicarboxylate]. In some embodiments, the crosslinker is optionally substituted sodium 4,4′-dihydroxy-[1,1′-biphenyl]-2,2′-dicarboxylate.
In some embodiments, the crosslinker is, or comprises:
[4,4′-dihydroxy-[1,1′-biphenyl]-2,2′-dicarboxylic acid], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 4,4′-dihydroxy-[1,1′-biphenyl]-2,2′-dicarboxylic acid, or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-4.1 or sodium 4-(4-(1,1-bis(4-hydroxyphenyl)ethyl)phenoxy)butane-1-sulfonate]. In some embodiments, the crosslinker is optionally substituted sodium 4-(4-(1,1-bis(4-hydroxyphenyl)ethyl)phenoxy)butane-1-sulfonate.
In some embodiments, the crosslinker is, or comprises:
[4-(4-(1,1-bis(4-hydroxyphenyl)ethyl)phenoxy)butane-1-sulfonic acid], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 4-(4-(1,1-bis(4-hydroxyphenyl)ethyl)phenoxy)butane-1-sulfonic acid, or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-5.1 or N1-(4-aminophenyl)benzene-1,4-diamine]. In some embodiments, the crosslinker is optionally substituted N1-(4-aminophenyl)benzene-1,4-diamine.
In some embodiments, the crosslinker is, or comprises:
[CLC-5.2 or sodium 3-(3,6-diamino-9H-carbazol-9-yl)propane-1-sulfonate]. In some embodiments, the crosslinker is optionally substituted sodium 3-(3,6-diamino-9H-carbazol-9-yl)propane-1-sulfonate.
In some embodiments, the crosslinker is, or comprises:
[3-(3,6-diamino-9H-carbazol-9-yl)propane-1-sulfonic acid], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 3-(3,6-diamino-9H-carbazol-9-yl)propane-1-sulfonic acid, or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-5.3 or N1,N1′-(1,3-phenylene)bis(benzene-1,4-diamine)]. In some embodiments, the crosslinker is optionally substituted N1,N1′-(1,3-phenylene)bis(benzene-1,4-diamine).
In some embodiments, the crosslinker is, or comprises:
[CLC-5.4 or potassium 3-((4-aminophenyl)(3-((4-aminophenyl)amino)phenyl)amino)propane-1-sulfonate]. In some embodiments, the crosslinker is optionally substituted potassium 3-((4-aminophenyl)(3-((4-aminophenyl)amino)phenyl)amino)propane-1-sulfonate.
In some embodiments, the crosslinker is, or comprises:
[3-((4-aminophenyl)(3-((4-aminophenyl)amino)phenyl)amino)propane-1-sulfonic acid], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 3-((4-aminophenyl)(3-((4-aminophenyl)amino)phenyl)amino)propane-1-sulfonic acid], or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-5.5 or potassium 3,3′-(1,3-phenylenebis((4-aminophenyl)azanediyl))bis(propane-1-sulfonate)]. In some embodiments, the crosslinker is optionally substituted 3,3′-(1,3-phenylenebis((4-aminophenyl)azanediyl))bis(propane-1-sulfonate).
In some embodiments, the crosslinker is, or comprises:
[3,3′-(1,3-phenylenebis((4-aminophenyl)azanediyl))bis(propane-1-sulfonic acid)], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 3,3′-(1,3-phenylenebis((4-aminophenyl)azanediyl))bis(propane-1-sulfonic acid), or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-6.1 or sodium 6-(3-(2-hydroxyethoxy)-2,2-bis((2-hydroxyethoxy)methyl)propoxy)hexane-1-sulfonate]. In some embodiments, the crosslinker is optionally substituted sodium 6-(3-(2-hydroxyethoxy)-2,2-bis((2-hydroxyethoxy)methyl)propoxy)hexane-1-sulfonate.
In some embodiments, the crosslinker is, or comprises:
[6-(3-(2-hydroxyethoxy)-2,2-bis((2-hydroxyethoxy)methyl)propoxy)hexane-1-sulfonic acid], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 6-(3-(2-hydroxyethoxy)-2,2-bis((2-hydroxyethoxy)methyl)propoxy)hexane-1-sulfonic acid, or a salt thereof.
In some embodiments, the crosslinker is, or comprises:
[CLC-6.2 or dimethyl 4,4′-((2,2-bis((4-(methoxycarbonyl)phenoxy)methyl)propane-1,3-diyl)bis(oxy))dibenzoate]. In some embodiments, the crosslinker is optionally substituted dimethyl 4,4′-((2,2-bis((4-(methoxycarbonyl)phenoxy)methyl)propane-1,3-diyl)bis(oxy))dibenzoate.
In some embodiments, the crosslinker is, or comprises:
[CLC-6.3 or (4-(3-(4-(hydroxymethyl)phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)phenyl)methanol]. In some embodiments, the crosslinker is optionally substituted (4-(3-(4-(hydroxymethyl)phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)phenyl)methanol.
In some embodiments, the crosslinker is, or comprises:
[CLC-6.4 or sodium 4-((4-(3-(4-(hydroxymethyl)phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)benzyl)oxy)butane-1-sulfonate]. In some embodiments, the crosslinker is optionally substituted sodium 4-((4-(3-(4-(hydroxymethyl)phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)benzyl)oxy)butane-1-sulfonate.
In some embodiments, the crosslinker is, or comprises:
[4-((4-(3-(4-(hydroxymethyl) phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)benzyl)oxy)butane-1-sulfonic acid], or a salt thereof. In some embodiments, the crosslinker is optionally substituted 4-((4-(3-(4-(hydroxymethyl)phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)benzyl)oxy)butane-1-sulfonic acid, or a salt thereof.
In some embodiments, the crosslinker is optionally substituted benzene-1,3-diamine, or a salt thereof; optionally substituted 3,5-diaminobenzoic acid, or a salt thereof; optionally substituted 2,2′-diamino-[1,1′-biphenyl]-4,4′-diol, or a salt thereof; optionally substituted sodium 4,4′-dihydroxy-[1,1′-biphenyl]-2,2′-dicarboxylate; optionally substituted 4,4′-dihydroxy-[1,1′-biphenyl]-2,2′-dicarboxylic acid, or a salt thereof; optionally substituted sodium 4-(4-(1,1-bis(4-hydroxyphenyl)ethyl)phenoxy)butane-1-sulfonate; optionally substituted 4-(4-(1,1-bis(4-hydroxyphenyl)ethyl)phenoxy)butane-1-sulfonic acid, or a salt thereof; optionally substituted N1-(4-aminophenyl)benzene-1,4-diamine; optionally substituted sodium 3-(3,6-diamino-9H-carbazol-9-yl)propane-1-sulfonate; optionally substituted 3-(3,6-diamino-9H-carbazol-9-yl)propane-1-sulfonic acid, or a salt thereof; optionally substituted N1,N1′-(1,3-phenylene)bis(benzene-1,4-diamine); optionally substituted potassium 3-((4-aminophenyl)(3-((4-aminophenyl)amino)phenyl)amino)propane-1-sulfonate; optionally substituted 3-((4-aminophenyl)(3-((4-aminophenyl)amino)phenyl)amino)propane-1-sulfonic acid], or a salt thereof; optionally substituted 3,3′-(1,3-phenylenebis((4-aminophenyl)azanediyl))bis(propane-1-sulfonate); optionally substituted 3,3′-(1,3-phenylenebis((4-aminophenyl)azanediyl))bis(propane-1-sulfonic acid), or a salt thereof; optionally substituted sodium 6-(3-(2-hydroxyethoxy)-2,2-bis((2-hydroxyethoxy)methyl)propoxy)hexane-1-sulfonate; or optionally substituted 6-(3-(2-hydroxyethoxy)-2,2-bis((2-hydroxyethoxy)methyl)propoxy)hexane-1-sulfonic acid, or a salt thereof; optionally substituted dimethyl 4,4′-((2,2-bis((4-(methoxycarbonyl)phenoxy)methyl)propane-1,3-diyl)bis(oxy))dibenzoate; optionally substituted (4-(3-(4-(hydroxymethyl)phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)phenyl)methanol [CLC-6.4 or sodium 4-((4-(3-(4-(hydroxymethyl) phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)benzyl)oxy)butane-1-sulfonate]; optionally substituted 4-((4-(3-(4-(hydroxymethyl) phenoxy)-2,2-bis((4-(hydroxymethyl)phenoxy)methyl)propoxy)benzyl)oxy)butane-1-sulfonic acid, or a salt thereof.
It is believed that when the cross-linker comprises an organic or sulfonyl-based salt, such as sodium salt, potassium salt, or lithium salt, the hydrophilicity of the resulting GO membrane could be increased, thereby increasing the total water flux.
It is believed that crosslinking the graphene oxide can also enhance the GO's mechanical strength and water permeable properties by creating strong chemical bonding and wide channels between graphene platelets to allow water to pass through the platelets easily, while increasing the mechanical strength between the moieties within the composite. In some embodiments, at least about 1%, about 5%, about 10%, about 20%, about 30%, about 40% about 50%, about 60%, about 70%, about 80%, about 90%, about 95%, or all of the graphene oxide platelets may be crosslinked. In some embodiments, the majority of the graphene material may be crosslinked. The amount of crosslinking may be estimated based on the weight of the cross-linker as compared with the total amount of graphene material.
In some embodiments, the weight ratio of cross-linker to GO (weight ratio=weight of cross-linker+weight of graphene oxide) can be about 1-30, about 0.25-30, about 0.25-0.5, about 0.5-1.5, about 1-5, about 3-7, about 5-10, about 7-12, about 10-15, about 12-18, about 15-20, about 18-25, about 20-30, or about 1, about 3 (for example 3 mg of meta-phenylenediamine cross-linker and 1 mg of graphene oxide), about 5, about 7, about 15, or any ratio in a range bounded by any of these values.
In some embodiments, the mass percentage of the graphene oxide relative to the total weight of the crosslinked graphene oxide can be about 4-80 wt %, about 4-75 wt %, about 5-70 wt %, about 7-65 wt %, about 7-60 wt %, about 7.5-55 wt %, about 8-50 wt %, about 8.5-50 wt %, about 15-50 wt %, about 1-5 wt %, about 3-8 wt %, about 5-10 wt %, about 7-12 wt %, about 10-15 wt %, about 12-17 wt %, about 15-20 wt %, about 17-23 wt %, about 20-25 wt %, about 23-28 wt %, about 25-30 wt %, about 30-40 wt %, about 35-45 wt %, about 40-50 wt %, about 45-55 wt %, about 50-70 wt %, about 6 wt %, about 13 wt %, about 16 wt %, about 25 wt %, about 50 wt %, or any percentage in a range bounded by any of these values.
In some embodiments, the crosslinked graphene oxide composite layer contains about 29-31 atom % O. In some embodiments, the crosslinked graphene oxide layer contains about 67-70 atom % C.
For some membranes, where there is a plurality of filtering layers, at least one layer can comprise a silica composite. In some embodiments, the crosslinked silica nanoparticle layer comprises a silica nanoparticle and a polyvinyl alcohol composite, or a SNP-PVA composite. In some embodiments, the silica composite is formed by reacting a mixture comprising silica nanoparticles and polyvinyl alcohol, which can result in covalent bonds being formed between the silica nanoparticles and the polyvinyl alcohol.
In some embodiments, the molecular weight of the PVA in the silica composite may be about 100-1,000,000 Daltons (Da), about 10,000-500,000 Da, about 10,000-50,000 Da, about 50,000-100,000 Da, about 70,000-120,000 Da, about 80,000-130,000 Da, about 90,000-140,000 Da, about 90,000-100,000 Da, about 95,000-100,000 Da, about 98,000 Da, or any molecular weight in a range bounded by any of these values.
In some embodiments the silica nanoparticles in the silica nanoparticles layer may define an average size ranging from about 5-1,000 nm, from about 6-500 nm, from about 7-100 nm, about 1-20 nm, about 5-15 nm, or size in a range bounded by or between any of these values. The average size for a set of nanoparticles can be determined by taking the average volume and then determining the diameter associated with a comparable sphere which displaces the same volume to obtain the average size. In some embodiments, the mass ratio of PVA to silica nanoparticles may be about 1-20 (a mixture that contains 20 mg of PVA and 1 mg of silica nanoparticles would have a mass ratio of 20), about 1-10, about 1-5, about 2-4, about 3, about 3-5, about 5-10, about 10-20, or any mass ratio on a range bounded by any of these values.
The silica composite can further comprise an additive. In some embodiments, the additive can comprise a borate salt, chloride salt, terephthalic-based acid, or any combination thereof.
A porous support may be any suitable material and in any suitable form upon which a layer, such as a layers of a GO-based composite, may be deposited or disposed. In some embodiments, the porous support can comprise hollow fibers or porous material. In some embodiments, the porous support may comprise a porous material, such as a polymer or a hollow fiber. Some porous supports can comprise a non-woven fabric. In some embodiments, the polymer may be polyamide (Nylon), polyimide (PI), polyvinylidene fluoride (PVDF), polyethylene (PE), polyethylene terephthalate (PET), polysulfone (PSF), polyether sulfone (PES), and/or mixtures thereof. In some embodiments, the polymer can comprise PET.
Some membranes further comprise a salt rejection layer, e.g. disposed on the crosslinked GO layer, such as a crosslinked GO composite layer. In some embodiments, the salt rejection layer can give the membrane low salt permeability. A salt rejection layer may comprise any material that is suitable for reducing the passage of ionic compounds, or salts. In some embodiments, the salt rejected, excluded, or partially excluded, can comprise KCl, MgCl2, CaCl2, NaCl, K2SO4, MgSO4, CaSO4, or Na2SO4. In some embodiments, the salt rejected, excluded, or partially excluded, can comprise NaCl. Some salt rejection layers comprise a polymer, such as a polyamide or a mixture of polyamides. In some embodiments, the polyamide can be a polyamide made from an amine (e.g. meta-phenylenediamine, para-phenylenediamine, ortho-phenylenediamine, piperazine, polyethylenimine, polyvinylamine, or the like) and an acyl chloride (e.g. trimesoyl chloride, isophthaloyl chloride, or the like). In some embodiments, the amine can be meta-phenylenediamine. In some embodiments, the acyl chloride can be trimesoyl chloride. In some embodiments, the polyamide can be made from a meta-phenylenediamine and a trimesoyl chloride (e.g. by a polymerization reaction of meta-phenylenediamine and trimesoyl chloride).
Some membranes may further comprise a protective coating. For example, the protective coating can be disposed on top of the membrane to protect it from the environment. The protective coating may have any composition suitable for protecting a membrane from the environment, Many polymers are suitable for use in a protective coating such as one or a mixture of hydrophilic polymers, e.g. polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP), polyethylene glycol (PEG), polyethylene oxide (PEO), polyoxyethylene (POE), polyacrylic acid (PAA), polymethacrylic acid (PMMA) and polyacrylamide (PAM), polyethylenimine (PEI), poly(2-oxazoline), polyethersulfone (PES), methyl cellulose (MC), chitosan, poly (allylamine hydrochloride) (PAH) and poly (sodium 4-styrene sulfonate) (PSS), and any combinations thereof. In some embodiments, the protective coating can comprise PVA.
Some embodiments include methods for making the aforementioned membrane. Some methods include coating the porous support with a crosslinked GO layer, such as a crosslinked GO composite layer. Some methods comprise of the addition steps of coating a porous support with a crosslinked silica nanoparticle layer. Some methods coat the support with the silica composite layer before coating the support with the crosslinked GO layer. In some embodiments, the method optionally comprises pre-treating the porous support. In some embodiments, the method can further comprise applying a salt rejection layer. Some methods also include applying a salt rejection layer on the resulting assembly, followed by additional curing of resulting assembly. In some methods, a protective layer can also be placed on the assembly. An example of a possible embodiment of making the aforementioned membrane is shown in
In some embodiments, the porous support can be optionally pre-treated to aid in the adhesion of a composite layer, such as a silica composite or a crosslinked graphene oxide composite layer, to the porous support. In some embodiments, the pretreatment can be applied to the porous support and then dried. For some pretreatments, the treatment can be selected from dopamine, and polyvinyl alcohol. For some solutions, the aqueous solution can comprise about 0.01 wt %, about 0.02, about 0.05 wt % about 0.1 wt % PVA. In some embodiments, the pretreated support can be dried at a temperature of 25° C., 50° C., 65° C., 75° C., or 90° C., for 2 minutes, 10 minutes, 30 minutes, 1 hour, or until the support is dry.
In some embodiments, coating the porous support with a crosslinked silica nanoparticle layer comprises: (a) mixing silica nanoparticles and polyvinyl alcohol to obtain an aqueous mixture, (b) applying the mixture to the porous support to achieve a coated substrate; (c) repeating step (b) as necessary to achieve the desired thickness; and (d) curing the coated support.
In some embodiments, mixing silica nanoparticles and polyvinyl alcohol to obtain an aqueous mixture of can be accomplished by dissolving appropriate amounts of silica nanoparticles and polyvinyl alcohol in water. Some methods comprise mixing at least two separate aqueous mixtures, e.g., a silica nanoparticle based mixture and a polyvinyl alcohol based mixture, then mixing appropriate mass ratios of the mixtures together to achieve the desired results. Other methods comprise of dissolving appropriate amounts by mass of silica nanoparticles and polyvinyl alcohol within a single aqueous mixture. In some embodiments, the mixture can be agitated at temperatures and times sufficient to ensure uniform dissolution of the solute. The result is a silica nanoparticle coating mixture.
In some embodiments, mixing silica nanoparticles and polyvinyl alcohol can further comprise adding an additive mixture to the dissolved silica nanoparticles and polyvinyl alcohol. In some embodiments, the additive mixture can also be dissolved in an aqueous solution. In some embodiments, the additive mixture can comprise additives selected from the group consisting of chloride salt, borate salt, and 2,5-dihydroxyterephthalic acid, all of which are described elsewhere herein.
In some embodiments, applying the silica nanoparticle mixture to the porous support can be done by methods known in the art for creating a layer of desired thickness. In some embodiments, applying the coating mixture to the substrate can be achieved by vacuum immersing the substrate into the coating mixture first, and then drawing the solution onto the substrate by applying a negative pressure gradient across the substrate until the desired coating thickness can be achieved. In some embodiments, applying the coating mixture to the substrate can be achieved by blade coating, spray coating, dip coating, die coating, or spin coating. In some embodiments, the method can further comprise gently rinsing the substrate with deionized water after each application of the coating mixture to remove excess loose material. In some embodiments, the coating is done such that a composite layer of a desired thickness is created. The desired thickness of membrane can be, for example, about 5-2000 nm, about 5-1000 nm, about 1000-2000 nm, about 10-500 nm, about 500-1000 nm, about 50-300 nm, about 10-200 nm, about 10-100 nm, about 10-50 nm, about 20-50 nm, or about 50-500 nm. In some embodiments, the number of layers can range from 1 to 250, from 1 to 100, from 1 to 50, from 1 to 20, from 1 to 15, from 1 to 10, or from 1 to 5. This process results in a fully coated substrate. The result is a silica nanoparticle coated support.
For some methods, curing the silica nanoparticle coated support can then be done at temperatures and time sufficient to facilitate crosslinking between the moieties of the aqueous mixture deposited on porous support. In some embodiments, the coated support can be heated at a temperature of between about 80-200° C., about 90-170° C., or about 90-150° C. In some embodiments, the substrate can be exposed to heating for duration of between about 1 minute to about 5 hours, about 15 minutes to about 3 hours, or about 30 minutes; with the time required decreasing for increasing temperatures. In some embodiments, the substrate can be heated at about 90-150° C. for about 1 minute to about 5 hours. The result is a cured membrane.
For some methods, coating the porous support with a crosslinked GO layer can comprise: (a) mixing graphene oxide material, cross-linker, and optional additive mixture in an aqueous solution to create an aqueous mixture; (b) applying the mixture to a porous support to achieve a coated substrate; (c) repeating step (b) as necessary to achieve the desired thickness; and (d) curing the coated support.
In some embodiments, mixing an aqueous mixture of graphene oxide material, polyvinyl alcohol and optional additives can be accomplished by dissolving appropriate amounts of graphene oxide material, polyvinyl alcohol, and additives (e.g. borate salt, calcium chloride, terephthalic-based acid, or silica nanoparticles) in water. Some methods comprise mixing at least two separate aqueous mixtures, e.g., a graphene oxide based mixture and a polyvinyl alcohol and additives based aqueous mixture, then mixing appropriate mass ratios of the mixtures together to achieve the desired results. Other methods comprise creating one aqueous mixture by dissolving appropriate amounts by mass of graphene oxide material, polyvinyl alcohol, and additives dispersed within a single solution. In some embodiments, the mixture can be agitated at temperatures and times sufficient to ensure uniform dissolution of the solute. The result is a crosslinked GO coating mixture.
For some methods, there can be an additional step of resting the coating mixture at about room temperature for about 30 min to about 12 hours to facilitate pre-reacting of the constituents of the coating mixture. In some embodiments, resting the coating mixture can be done for about 1 hour to about 6 hours. In some embodiments, resting the coating mixture can be done for about 3 hours. It is believed that resting the coating solution allows the graphene oxide and the cross-linker to begin covalently bonding in order to facilitate a final crosslinked layer. The result is a crosslinked GO coating mixture.
In some embodiments, applying the mixture to the porous support can be done by methods known in the art for creating a layer of desired thickness. In some embodiments, applying the coating mixture to the substrate can be achieved by vacuum immersing the substrate into the coating mixture first, and then drawing the solution onto the substrate by applying a negative pressure gradient across the substrate until the desired coating thickness can be achieved. In some embodiments, applying the coating mixture to the substrate can be achieved by blade coating, spray coating, dip coating, die coating, or spin coating. In some embodiments, the method can further comprise gently rinsing the substrate with deionized water after each application of the coating mixture to remove excess loose material. In some embodiments, the coating is done such that a composite layer of a desired thickness is created. The desired thickness of membrane can range from about 5-2000 nm, about 5-1000 nm, about 1000-2000 nm, about 10-500 nm, about 500-1000 nm, about 50-300 nm, about 10-200 nm, about 10-100 nm, about 10-50 nm, about 20-50 nm, about 50-500 nm, or any combination thereof. In some embodiments, the number of layers can range from 1 to 250, from 1 to 100, from 1 to 50, from 1 to 20, from 1 to 15, from 1 to 10, or from 1 to 5. This process results in a fully coated substrate. The result is a coated support.
For some methods, curing the coated support can then be done at temperatures and time sufficient to facilitate crosslinking between the moieties of the aqueous mixture deposited on porous support. In some embodiments, the coated support can be heated at a temperature of between about 50-200° C., about 90-170° C., or about 70-150° C. In some embodiments, the substrate can be exposed to heating for duration of between about 1 minute to about 5 hours, about 15 minutes to about 3 hours, or about 30 minutes; with the time required decreasing for increasing temperatures. In some embodiments, the substrate can be heated at about 70-150° C. for about 30 minutes. The result is a cured membrane.
In some embodiments, the method for fabricating membranes further comprises applying a salt rejection layer to the membrane or a cured membrane to yield a membrane with a salt rejection layer. In some embodiments, the salt rejection layer can be applied by dipping the cured membrane into a solution of precursors in mixed solvents. In some embodiments, the precursors can comprise an amine and an acyl chloride. In some embodiments, the precursors can comprise meta-phenylenediamine and trimesoyl chloride. In some embodiments, the concentration of meta-phenylenediamine can range from about 0.01-10 wt %, about 0.1-5 wt %, about 5-10 wt %, about 1-5 wt %, about 2-4 wt %, about 4 wt %, about 2 wt %, or about 3 wt %. In some embodiments, the trimesoyl chloride concentration can range from about 0.001 vol % to about 1 vol %, about 0.01-1 vol %, about 0.1-0.5 vol %, about 0.1-0.3 vol %, about 0.2-0.3 vol %, about 0.1-0.2 vol %, or about 0.14 vol %. In some embodiments, the mixture of meta-phenylenediamine and trimesoyl chloride can be allowed to rest for a sufficient amount of time such that polymerization can take place before the dipping occurs. In some embodiments, the method comprises resting the mixture at room temperature for about 1-6 hours, about 5 hours, about 2 hours, or about 3 hours. In some embodiments, the method comprises dipping the cured membrane in the coating mixture for about 15 seconds to about 15 minutes; about 5 seconds to about 5 minutes, about 10 seconds to about 10 minutes, about 5-15 minutes, about 10-15 minutes, about 5-10 minutes, or about 10-15 seconds.
In other embodiments, the salt rejection layer can be applied by coating the cured membrane in separate solutions of aqueous meta-phenylenediamine and a solution of trimesoyl chloride in an organic solvent. In some embodiments, the meta-phenylenediamine solution can have a concentration in a range of about 0.01-10 wt %, about 0.1-5 wt %, about 5-10 wt %, about 1-5 wt %, about 2-4 wt %, about 4 wt %, about 2 wt %, or about 3 wt %. In some embodiments, the trimesoyl chloride solution can have a concentration in a range of about 0.001-1 vol %, about 0.01-1 vol %, about 0.1-0.5 vol %, about 0.1-0.3 vol %, about 0.2-0.3 vol %, about 0.1-0.2 vol %, or about 0.14 vol %. In some embodiments, the method comprises dipping the cured membrane in the aqueous meta-phenylenediamine for a period of about 1 second to about 30 minutes, about 15 seconds to about 15 minutes; or about 10 seconds to about 10 minutes. In some embodiments, the method then comprises removing excess meta-phenylenediamine from the cured membrane. In some embodiments, the method then comprises dipping the cured membrane into the trimesoyl chloride solution for a period of about 30 seconds to about 10 minutes, about 45 seconds to about 2.5 minutes, or about 1 minute. In some embodiments, the method comprises subsequently drying the resultant assembly in an oven to yield a membrane with a salt rejection layer. In some embodiments, the cured membrane can be dried at about 45° C. to about 200° C. for a period about 5 minutes to about 20 minutes, at about 75° C. to about 120° C. for a period of about 5 minutes to about 15 minutes, or at about 90° C. for about 10 minutes. This process results in a membrane with a salt rejection layer.
In some embodiments, the method for fabricating a membrane can further comprises subsequently applying a protective coating on the membrane. In some embodiments, the applying a protective coating comprises adding a hydrophilic polymer layer. In some embodiments, applying a protective coating comprises coating the membrane with a PVA aqueous solution. Applying a protective layer can be achieved by methods such as blade coating, spray coating, dip coating, spin coating, and etc. In some embodiments, applying a protective layer can be achieved by dip coating of the membrane in a protective coating solution for about 1 minute to about 10 minutes, about 1-5 minutes, about 5 minutes, or about 2 minutes. In some embodiments, the method further comprises drying the membrane at a about 75° C. to about 120° C. for about 5 minutes to about 15 minutes, or at about 90° C. for about 10 minutes. The result is a membrane with a protective coating.
In some embodiments, methods of extracting liquid water from an unprocessed aqueous solution containing dissolved solutes, for applications such as pollutant removal or desalination are described. In some embodiments, a method for removing a solute from an unprocessed solution can comprise exposing the unprocessed solution to one or more of the aforementioned membranes. In some embodiments, the method further comprises passing the unprocessed solution through the membrane, whereby the water is allowed to pass through while solutes are retained, thereby reducing the solute content of the resulting water. In some embodiments, passing the unprocessed water containing solute through the membrane can be accomplished applying a pressure gradient across the membrane. Applying a pressure gradient can be by supplying a means of producing head pressure across the membrane. In some embodiments, the head pressure can be sufficient to overcome osmotic back pressure.
In some embodiments, providing a pressure gradient across the membrane can be achieved by producing a positive pressure in the first reservoir, producing a negative pressure in the second reservoir, or producing a positive pressure in the first reservoir and producing a negative pressure in the second reservoir. In some embodiments, a means of producing a positive pressure in the first reservoir can be accomplished by using a piston, a pump, a gravity drop, and/or a hydraulic ram. In some embodiments, a means of producing a negative pressure in the second reservoir can be achieved by applying a vacuum or withdrawing fluid from the second reservoir.
The following embodiments are specifically contemplated.
It has been discovered that embodiments of the selectively permeable membranes described herein have improved performance as compared to other selectively permeable membranes. These benefits are further demonstrated by the following examples, which are intended to be illustrative of the disclosure, but are not intended to limit the scope or underlying principles in any way.
GO was prepared from graphite using the modified Hummers method. Graphite flakes (2.0 g, Sigma Aldrich, St. Louis, Mo., USA, 100 mesh) were oxidized in a mixture of NaNO3 (2.0 g, Aldrich), KMnO4 of (10 g, Aldrich) and concentrated H2SO4 (96 mL, 98%, Aldrich) at 50° C. for 15 hours. The resulting paste like mixture was poured into 400 g of ice followed by adding 30 mL of hydrogen peroxide (30%, Aldrich). The resulting solution was then stirred at room temperature for 2 hours to reduce the manganese dioxide, then filtered through a filter paper and washed with DI water. The solid was collected and then dispersed in DI water with stirring, centrifuged at 6300 rpm for 40 minutes, and the aqueous layer was decanted. The remaining solid was then dispersed in DI water again and the washing process was repeated 4 times. The purified GO was then dispersed in DI water under sonication (power of 10 W) for 2.5 hours to get the GO dispersion (0.4 wt %) as GO-1.
To a mixture of 3-nitrophenol (6.95 g, 0.05 mol, Aldrich) in ethanol (50 mL, Aldrich), was added NaOH aqueous solution (25 mL, 12 M, Aldrich), and zinc powder (13 g, 0.2 mol, Aldrich) under a nitrogen atmosphere (Airgas, San Marcos, Calif., USA). The resulting mixture was stirred for 10 hours, then filtered. The filtrate was acidified by acetic acid (Aldrich) to pH of 4, and a precipitate formed. The solid was collected by filtration, washing with water to neutral, and drying under vacuum using a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher Scientific Waltham, Mass. USA) at 60° C. at 2 torr to afford desired product (3.8 g, 70% yield), or CLC-3.1. The compound was characterized by LCMS: calc'd for C12H13N2O2 (M+H): 217.1; found: 217. 1H NMR (DMSO): δ 8.9 (bs, 4H), 6.77 (bs, 2H), 6.15 (bs, 4H) ppm.
A mixture of methyl 2-bromo-5-methoxybenzoate (10 g, 46.8 mmol, Aldrich), and freshly activated copper powder (12 g, 189 mmol, Aldrich) in anhydrous dimethylformamide (DMF) (50 mL, Aldrich) was heated at 160° C. for 16 hours under an argon atmosphere (Airgas). The reaction mixture was then cooled to room temperature and poured into ethyl acetate (300 mL, Aldrich). After filtering off the precipitate, the organic precipitate was washed with water and brine, dried over Na2SO4 (Aldrich), loaded on silica gel (Aldrich), and then purified by flash column chromatography using eluents of hexanes/dichloromethane (100% to 50%, Aldrich). The desired fraction was collected and removal of solvents by drying in a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher Scientific Waltham, Mass. USA) at 60° C. at 2 torr gave a pale yellow oil (4.7 g, in 70% yield), or IC-1. 1H NMR (CDCl3) δ 7.50 (d, J=2.4 Hz, 2H), 7.13 (d, J=8.3 Hz, 2H), 7.07 (dd, J=2.4 and 8.3 Hz, 2H), 3.89 (s, 6H), 3.64 (2, 6H).
To a solution of dimethyl 4,4′-dimethoxy-[1,1′-biphenyl]-2,2′-dicarboxylate (4.7 g, 14.2 mmol), or IC-1, in anhydrous dichloromethane (60 mL, Aldrich), BBr3 solution in dichloromethane (60 mL, 1M, 60 mmol) (Aldrich) was added at −78° C. using evaporating liquid carbon dioxide (Airgas) to regulate the temperature. The whole solution was then kept stirring at −78° C. and then allowed to warm up slowly to room temperature overnight. The resulting mixture was then poured into an ice water mixture (200 mL) and then extracted three times by ethyl acetate (3×300 mL, Aldrich). The organic phase was washed with brine, dried over Na2SO4 (Aldrich), concentrated and reprecipitated in ethyl acetate/hexanes (Aldrich) to give a white solid (3.8 g, in 98% yield), or IC-2. 1H NMR (DMSO) δ 12.20 (s, 2H), 9.56 (s, 2H), 7.20 (d, J=2.0 Hz, 2H), 6.90 (d, J=8.3 Hz, 2H), 6.86 (dd, J=2.0 and 8.3 Hz, 2H). LCMS: calc'd for C14H9O6 (M−H): 273.0; Found: 273.
To a solution of 4,4′-dihydroxy-[1,1′-biphenyl]-2,2′-dicarboxylic acid (3.8 g, 14 mmol), or IC-2, in 30 mL methanol (Aldrich), NaOH aqueous solution (1.12 g, 28 mmol in 10 mL water, Aldrich) was added. The whole mixture was stirred for 30 min and then the solvents were removed using a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher) at 60° C. at 2 torr to give a white solid (4.45 g, 100% yield), or CLC-3.2. 1H NMR (D2O) δ 7.14 (d, J=8.4 Hz, 2H), 6.91 (d, J=2.6 Hz, 2H), 6.82 (dd, J=2.6 Hz and 8.4 Hz, 2H).
To a stirring quantity of tert-butanol (90 mL, Aldrich) at room temperature, 4,4′,4″-(ethane-1,1,1-triyl)triphenol (5 g, 16 mmol, Aldrich) was added followed by sodium tert-butoxide (1.57 g, 16 mmol, Aldrich). The mixture was then stirred at 110° C. for 15 minutes. Subsequently 1,4-butanesultone (1.67 mL, 16 mmol, Aldrich) was added to the mixture and the reaction was stirred overnight. After about 16 hours, the reaction was then cooled. To the solution hexanes (200 mL, Aldrich) were added and the solution was stirred for 30 minutes. The collected precipitate was then washed again for 30 minutes in fresh hexanes solution (about 500 mL, Aldrich). Then the collected precipitate was put in isopropanol (400 mL, Aldrich) and then stirred for 2 hours. The final step added hexanes (400 mL, Aldrich) to the solution and after 5 minutes of stirring, the precipitate was collected. The product was dried at 60° C. at 2 torr in a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher Scientific Waltham, Mass. USA) overnight to give a white powder (6.25 g, 82.4% yield), or CLC-4.1. 1H-NMR (D2O): δ 1.63 (4H, m), 1.77 (3H, s), 2.72 (2H, t), 3.65 (2H, t), 6.51 (6H, t), 6.76 (6H, t).
Benzene-1,4-diamine (5.4 g, 50 mmol) (Aldrich) and 1-fluoro-4-nitrobenzene (5.3 mL, 50 mmol) (Aldrich) were dissolved in dimethylsulfoxide (75 mL, Aldrich) and potassium carbonate (13.8 g, 100 mmol, Aldrich) was added. The reaction mixture was then heated in an oil bath at 90° C. and stirred overnight under nitrogen atmosphere (Airgas). The reaction mixture was cooled to room temperature and added to DI water (250 mL) in a slow stream and stirred till a solid precipitated out. The reaction mixture was then filtered out and the resulting dark brown solid was washed with plenty of DI water. Flash column chromatography on silica gel (Aldrich) eluted with 20% to 40% ethyl acetate in hexanes (Aldrich) provided the compound (6.1 g, 53%), or IC-3.
A mixture of N-(4-nitrophenyl)benzene-1,4-diamine (2.0 g, 8.7 mmol), or IC-3, palladium on carbon (0.5 g, 5%, Aldrich) in ethanol (200 mL, Aldrich) was hydrogenated at 30 psi overnight. After being filtered off the catalyst, the solution was concentrated, then re-precipitated in dichloromethane/hexanes to give a solid (1.15 g, in 66% yield), or CLC-5.1. Confirmed by LCMS: calc'd for C12H14N3 (M+H): 200.1; Found: 200.
A suspension of Cu(NO3)2.3H2O (Aldrich) in acetic acid/acetic anhydride (20 mL/30 mL, Aldrich) was stirred for 1.5 hours at room temperature, then to the mixture, 9H-carbazole (4.18 g, 25 mmol, Aldrich) was added in small portion with cold water bath at 15° C. While the mixture was kept stirring, the mixture was warmed up to room temperature over a period of 30 min. and then subsequently heated at 90° C. for 30 min. After being cooled to room temperature, the mixture was poured into water (250 mL) and the resulting precipitate was filtered, washed with water, dried in a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher Scientific Waltham, Mass. USA) at 60° C. at 2 torr. The resulting solid was re-dissolved in acetone (Aldrich) and loaded on silica gel (Aldrich), then purified by flash column chromatography using eluents of hexanes/dichloromethane (3:2 to 1:3, Aldrich). The desired fractions were collected, concentrated and precipitated by methanol (Aldrich) to give a yellow solid (1.9 g, in 30% yield), or IC-4. Confirmed by LCMS: calculated for C12H6N3O4(M−H): 256.0; Found: 256.
To a suspension of 3,6-dinitro-9H-carbazole (0.74 g, 2.9 mmol), or IC-4, in anhydrous DMF (20 mL, Aldrich), was added sodium t-butoxide (0.285 g, 3 mmol, Aldrich), and the solution turned to red immediately. To the resulted solution, 1,3-propanesultone (0.44 g, 3.6 mmol, Aldrich) was added, then the whole solution was then heated at 80° C. for 2.5 hours. After being cooled to room temperature, the mixture was then poured into isopropanol (300 mL, Aldrich) to give yellow precipitate, which was filtered and dried to give product (1.05 g, in 90% yield), or IC-5. Confirmed by LCMS: calculated for C15H12N3NaO7S: 401.0; Found: 401.
A mixture of sodium 3-(3,6-dinitro-9H-carbazol-9-yl)propane-1-sulfonate (1.0 g, 2.5 mmol), or IC-5, palladium on carbon (5%, 0.5 g, Aldrich) in water/methanol (20 mL/100 mL, Aldrich) was hydrogenated at 30 psi for 5 hours. After being filtered off the catalyst, the solution was concentrated to 5 mL and then poured into isopropanol (50 mL, Aldrich). Then, the resulting suspension was poured into diethyl ether (200 mL, Aldrich) to give white precipitate, which was collected by filtration and dried in air as desired product (0.8 g, in 92% yield), or CLC-5.2. Confirmed by LCMS: calculated for C15H16N3O3S (M−Na): 318.1; Found: 318.
A mixture of 4-fluoro-1-nitrobenzene (10.6 mL, 100 mmol, Aldrich), meta-phenylenediamine (5.4 g, 50 mmol, Aldrich) and potassium carbonate (16.6 g, 120 mmol, Aldrich) in anhydrous dimethyl sulfoxide (DMSO) (80 mL, Aldrich) was heated to 105° C. for 20 hours. The resulting mixture was poured into water (250 mL) slowly and then extracted with dichloromethane (500 mL, Aldrich). The organic was washed with brine, dried over Na2SO4, then loaded on silica gel (Aldrich) for flash column chromatography using eluents of dichloromethane/hexanes (1:10 to 3:2, Aldrich). The desired fractions were collected and concentrated to give orange solid (4.8 g, in 27% yield), IC-6. Confirmed by LCMS: calculated for C18H14N4O4: 350.1; Found: 350.
A suspension of N1,N3-bis(4-nitrophenyl)benzene-1,3-diamine (2.0 g), or IC-6, palladium on carbon (0.75 g, 5%, Aldrich) in water/ethanol (40 mL/80 mL, Aldrich) was hydrogenated under 30 psi for 16 hours. After being filtered off the catalyst, the solution was concentrated, poured into isopropanol (100 mL, Aldrich). The solid was collected after filtration and dried under vacuum using a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher) at 60° C. at 2 torr to give 1.0 g product in 60% yield, or CLC-5.3. Confirmed by LCMS: calculated for C18H19N4(M+H): 291; Found: 291.
To a mixture of N1,N3-bis(4-nitrophenyl)benzene-1,3-diamine (1.0 g, 2.86 mmol), or IC-6, K2CO3 (0.414 g, 3 mmol) (Aldrich) in anhydrous dimethyl sulfoxide (DSMO) (10 mL) (Aldrich), was added 1,3-propanesultone (0.732 g, 6 mmol) (Aldrich). The whole mixture was then heated to 80° C. for 2 days. After cooling to room temperature, the mixture was then poured into isopropanol (200 mL) (Aldrich). The resulting orange precipitate was then filtered and then dried in a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher) at 60° C. at 2 torr for 3 hours to give a solid (1.4 g, in 96% yield), or IC-7. Confirmed by LCMS: calculated for C21H19KN4O7S (M−): 510.1; Found: 510.
A suspension of potassium 3-((4-nitrophenyl)(3-((4-nitrophenyl)amino)phenyl)amino)propane-1-sulfonate (1.4 g), or IC-7, palladium on carbon (5%, 0.75 g) (Aldrich) in water/ethanol (40 mL/80 mL) (Aldrich) was hydrogenated under 30 psi for 16 hours. After being filtered off the catalyst, the solution was concentrated, poured into isopropanol (100 mL) (Aldrich). The solid was collected after filtration and dried under vacuum using a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher) at 60° C. at 2 torr to give 0.5 g product in 41% yield, or CLC-5.4. Confirmed by LCMS: calculated for C21H25N4O3S (M+H): 413; Found: 413.
To a mixture of N1,N3-bis(4-nitrophenyl)benzene-1,3-diamine (1.0 g, 2.86 mmol), or IC-6, K2CO3 (0.414 g, 3 mmol, Aldrich) in anhydrous dimethyl sulfoxide (DSMO) (10 mL, Aldrich), was added 1,3-propanesultone (1.464 g, 12 mmol, Aldrich). The whole mixture was then heated to 80° C. for 2 days. After cooling to room temperature, the mixture can then be poured into isopropanol (200 mL, Aldrich). The resulting precipitate is then filtered and then dried in a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher) at 60° C. at 2 torr for 3 hours to give a solid, or IC-8.
A suspension of potassium 3-((4-nitrophenyl)(3-((4-nitrophenyl)amino)phenyl)amino)propane-1-sulfonate (1.83 g), or IC-8, palladium on carbon (0.75 g, 5%, Aldrich) in water/ethanol (40 mL/80 mL, Aldrich) can be hydrogenated under 30 psi for 16 hours. After being filtered off the catalyst, the solution can be concentrated and then poured into isopropanol (100 mL, Aldrich). The solid can then be collected after filtration and dried under vacuum using a vacuum oven (Thermo Scientific Precision 6500, Thermo Fisher) at 60° C. at 2 torr to give the product, or CLC-5.5.
While stirring a solution of tert-butanol (100 mL, Aldrich) at room temperature, pentaerythritol ethoxylate (7 g, 22.4 mmol, Aldrich 416150, Mn=270 avg, % EO/OH, Aldrich) was added followed by sodium tert-butoxide (2.15 g, 22.4 mmol, Aldrich). Continuing stirring, the mixture was then heated to 110° C. for 70 minutes. Subsequently, 1,4-butanesultone (2.29 mL, 22.4 mmol, Aldrich) was added to the mixture and the reaction stirred overnight. After 17 hours of reaction, the excess solution was decanted. The precipitates were then washed with hexanes (Aldrich). The precipitates were then dissolved in methanol (125 mL, Aldrich) and dried in vacuo in a 50° C. bath giving a viscous, transparent wax, or CLC-6.1 (8.77 g, yield 73%). 1H-NMR (D2O): δ 1.7-1.8 (4H, m), 2.90 (2H, t), 3.3 (8H, s), 3.4-3.7 (21H, m).
While stirring N,N′-dimethylformamide (100 mL) (Aldrich) at room temperature, pentaerythritol tetrabromide (6 g, 15.5 mmol, Aldrich) was added followed by methyl 4-hydroxybenzoate (9.42 g, 61.9 mmol, Aldrich), and then lastly potassium carbonate (27.80 g, 201.5 mmol, Aldrich). The resulting mixture was then heated to 150° C. and the reaction was stirred overnight. After about 22 hours, the reaction was then cooled to room temperature and the contents of the flask poured over DI water (1000 mL) and extracted with ethyl acetate (800 mL, Aldrich). The organic layer was collected and rotary evaporated (roto-vaped) under reduced pressure (R-215, Buchi Corp. New Castle, Del. USA). The resulting product was then concentrated by performing column chromatography using a gradient of hexanes (Aldrich) to ethyl acetate (Aldrich) to elute the product to give a white powder, or CLC-6.2 (7.19 g, 69% yield). 1H-NMR (TCE): δ 3.8 (12H, s), 4.4 (8H, s), 6.9 (8H, d), 7.9 (8H, d).
A solution of 50 mL of anhydrous tetrahydrofuran was stirred and cooled in an ice bath at 0° C. Then, dimethyl 4,4′-((2,2-bis((4-(methoxycarbonyl)phenoxy)methyl)propane-1,3-diyl)bis(oxy))dibenzoate (6.5 g, 9.7 mmol), or CLC-6.2, was added. Next, LiAlH4 (1M in diethyl ether, 58 mL, 58.2 mmol, Aldrich) cooled to 0° C. was added drop wise. Then, the solution was allowed to warm to room temperature and then stirred for 4 hours. The resulting solution was then poured over chilled water (1000 mL). Next HCl (1M, Aldrich) was added until neutralization. Then, the solution was extracted with ethyl acetate (800 mL, Aldrich). The resulting solution was purified by performing column chromatography using a gradient of ethyl acetate (Aldrich) and methanol (Aldrich) to give a white powder, or CLC-6.3 (3.44 g, 63.5% yield). 1H-NMR (DMSO): δ 4.25 (8H, s), 4.39 (8H, s), 5.04 (4H, s), 6.91 (8H, d), 7.21 (8H, d).
To a stirring quantity of tert-butanol (60 mL, Aldrich) at room temperature dihydrogen (((2,2-bis((4-(hydroxymethyl)phenoxy)methyl)-propane-1,3-diyl)bis(oxy))bis-(4,1-phenylene))-dimethanolate, or CLC-6.3, was added followed by sodium tert-butoxide (566 mg, 5.89 mmol, Aldrich). Still stirring, the mixture was then heated to 110° C. for 40 minutes. Subsequently, 1,4-butane sultone (0.60 mL, 5.89 mmol, Aldrich) was added and the reaction was stirred overnight after adding additional tert-butanol (75 mL, Aldrich) and N,N′-dimethylformamide (20 mL, Aldrich) to the reaction mixture. After 24 hours, the product was formed into precipitate by adding hexanes (400 mL, Aldrich). The resulting solution was then stirred for 15 minutes and then filtered. The collected precipitate was then placed back into hexanes (100 mL, Aldrich). After another 15 minutes, the precipitate was then filtered again. Then the precipitate was then added into a mixture of hexanes (100 mL, Aldrich) and isopropanol (30 mL, Aldrich). After 15 minutes, the precipitate was then filtered and then dried at 60° C. in a vacuum oven at 2 torr (Thermo Scientific Precision 6500, Thermo Fisher Scientific Waltham, Mass. USA) for 4 hours to give a white powder, or CLC-6.4 (3.25 g, 76.8% yield). 1H-NMR (DMSO): δ 1.56 (4H, m), 2.50 (2H, m), 4.25-4.38 (16H, m), 5.06 (2H, s), 6.93 (8H, d), 7.20 (8H, d).
Obtaining a Support:
Porous substrates were obtained to be porous supports from various sources and materials: PET (Hydranautics, San Diego, Calif. USA), PET2 (Hydranautics), and polyamide (Nylon) (0.1 μm pore, Aldrich). Selected substrates, corresponding to embodiments shown in Table 1 and Table 2, were trimmed to a 7.6 cm diameter. In the embodiments, where the substrates were going to be in physical communication with a PVA containing layer, the substrates were pretreated with PVA. Unless otherwise specified, for all other embodiments the substrates were pretreated with dopamine.
PVA Substrate Pre-Treatment:
A 7.6 cm diameter substrate was dipped into a 0.05 wt % PVA (Aldrich) in DI water solution. The substrate was then dried in an oven (DX400, Yamato Scientific Co., Ltd. Tokyo, Japan) at 65° C. to yield a pretreated substrate.
Dopamine Substrate Pre-Treatment:
A 7.6 cm diameter substrate was dip-coated in a dopamine solution (2 g/L dopamine (Aldrich) and 1.3 g/L Trizma base buffer (Aldrich) at pH 8.5. The dopamine was polymerized to form polydopamine on the substrate. Then, the polydopamine-coated substrate was dried in oven (DX400, Yamato Scientific Co., Ltd. Tokyo, Japan) at 65° C. The result was a pre-treated substrate.
The procedure for creating a crosslinked GO coating mixture is dependent on the variety of cross-linker used. All cross-linkers with the exception of PVA have a resting step to ensure pre-reaction of the GO and the cross-linker before curing.
Preparation of GO-PVA Coating Mixture:
A 10 mL of PVA solution (2.5 wt %) (CLC-1) was prepared by dissolving appropriate amounts of PVA (Aldrich) in DI water. Then, all the solutions GO-1 (1 mL) and PVA-1 in an appropriate amount to achieve the mass ratios of Table 1 were combined with 10 mL of DI water and sonicated for 6 minutes to ensure uniform mixing to create a crosslinked GO coating solution.
First the GO dispersion, GC-1, was diluted with DI water to create a 0.1 wt % GO aqueous solution. Second, a 0.1 wt % aqueous solution of cross-linker was created by dissolving appropriate amounts of cross-linker (e.g., CLC-1, CLC-2.1, etc.) in DI water. For CLC-2.1 and CLC-2.2, metaphenylenediamine (Aldrich) and 3, 5-diaminobenzoic acid (MPD w/COOH) (Aldrich) were both bought commercially. A coating mixture for the embodiment was then created by mixing the aqueous solutions of 0.1 wt % CLC-1 and 0.1 wt % GO at appropriate weight ratios to achieve the mass ratios in Table 1. The resulting solution was then rested for about 3 hours, or nominally until the GO and amine pre-reacted. The result was a crosslinked GO coating solution.
A 10 mL PVA solution (2.5 wt %) was prepared by dissolving appropriate amounts of PVA (CLC-1) (Aldrich) in DI water. Similarly, a 10 mL Si-nanoparticle solution (2.5 wt %) was prepared by dissolving appropriate amounts of SiO2 (5-15 nm, Aldrich) in DI water. Then, the solutions GO-1 (1 mL) and PVA-1 were combined in an appropriate amount to achieve the mass ratios of Table 2 and was further combined with 10 mL of DI water and sonicated for 6 minutes to ensure uniform mixing to create a crosslinked SiO2 nanoparticle coating solution.
Crosslinked GO Mixture Application by Filtration:
For the embodiments identified in Table 1 where the application method was by filtration, the crosslinked GO coating solution was filtered through the pretreated substrate under gravity to draw the solution through the substrate such that a coating layer of the desired thickness was deposited on the support. The resulting membrane was then placed in an oven (DX400, Yamato Scientific) at the identified temperature for the identified time to facilitate crosslinking. This process generated a membrane without either a crosslinked SiO2 nanoparticle layer or a salt rejection layer.
Crosslinked GO Mixture Application by Dip Coating:
For the embodiments identified in Table 1 where the application method was by dip coating, the pretreated substrate is then coated in the Crosslinked GO coating mixture by dip coating the substrate in the coating mixture. Next, the substrate is then rinsed completely in DI water to remove any excess particles. The aforementioned process can be repeated, dipping the substrate into the coating mixture and then rinsing with DI water for the prescribed number of cycles to prepare the desired number of layers or thickness of the coating layer. The resulting membrane is then kept in an oven (DX400, Yamato Scientific) at the identified temperature for the identified time facilitate further crosslinking. The result will then be a membrane without either a crosslinked SiO2 nanoparticle layer or a salt rejection layer.
Crosslinked SiO2 Nanoparticle Mixture Application by Filtration:
For the embodiments identified in Table 2, the crosslinked SiO2 nanoparticle coating solution was filtered through the pretreated substrate under gravity to draw the solution through the substrate such that a coating layer of the desired thickness was deposited on the support. The resulting membrane was then placed in an oven (DX400, Yamato Scientific) at 90° C. for 30 minutes to facilitate crosslinking. This process generated a coated substrate.
Crosslinked GO Mixture Application by Filtration:
For the embodiments identified in Table 2, the crosslinked GO coating solution was filtered through the coated substrate under gravity to draw the solution through the substrate such that a coating layer of the desired thickness was deposited on the support. The resulting membrane was then placed in an oven (DX400, Yamato Scientific) at the identified temperature for the identified time to facilitate crosslinking. This process generated a membrane with a crosslinked SiO2 nanoparticle layer but without a salt rejection layer.
To enhance the salt rejection capability of the membranes, selected embodiments, identified in Table 3 for those without an SiO2 nanoparticle layer or in Table 4 for those with an SiO2 nanoparticle layer, were additionally coated with a polyamide salt rejection layer. A 3.0 wt % MPD aqueous solution was prepared by diluting an appropriate amount of MPD (Aldrich) in DI water. A 0.14 vol % trimesoyl chloride solution was made by diluting an appropriate amount of trimesoyl chloride (Aldrich) in isoparrifin solvent (Isopar E & G, Exxon Mobil Chemical, Houston Tex., USA). The GO-MPD coated membrane was then dipped in the aqueous solution of 3.0 wt % of MPD (Aldrich) for a period of 10 seconds to 10 minutes depending on the substrate and then removed. Excess solution remaining on the membrane was then removed by air dry. Then, the membrane was dipped into the 0.14 vol % trimesoyl chloride solution for 10 seconds and removed. The resulting assembly was then dried in an oven (DX400, Yamato Scientific) at 120° C. for 3 minutes. This process resulted in membranes with a salt rejection layer.
Selected membranes were coated with a protective layer as shown in Table 4. For MD-4.1.41.2.1, a PVA solution of 1.5 wt % was prepared by stirring 15 g of PVA (Aldrich) in 1 L of DI water at 90° C. for 20 minutes until all granules dissolve. The solution was then cooled to room temperature. The substrate was immersed in the solution for 10 minutes and then removed. Excess solution remaining on the membrane was then removed by paper wipes. The resulting assembly was dried in an oven (DX400, Yamato Scientific) at 90° C. for 30 minutes. A membrane with a protective coating can thus be obtained. Similar membranes were also coated by varying the concentration of PVA accordingly.
For Comparative Example 2.1.1, comparative membranes (CMDs), CMD-1.1 thru CMD-1.2 were created by stock substrate components of polysulfone membrane (PSF) (Sterlitech Corporation, Kent, Wash., USA) and polypropolyene (PP) filtration membrane (Celgard LLC, Charlotte, N.C., USA). For CMD-1.3, a PVA/PP membrane was created by immersions of a PP filtration membrane in a PVA/water solution (Aldrich) for 10 minutes and then drying the membrane in an oven (DX400, Yamato Scientific) at 90° C. for about 30 minutes.
Comparative membranes CMD-2.1.1 thru CMD-2.2.2 were also made using methods similar to Examples 2.1.1 thru Example 2.2.1 for membranes without a SiO2 nanoparticle layer with the exceptions outlined in Table 5.
XPS Analysis: Membranes MD-1.1.31.1.1 and MD-1.1.41.1.1 were analyzed by X-ray photoelectron spectroscopy (XPS) to determine the relative distribution of the atomic spectra. The procedures for XPS are similar to those known by those skilled in the art. The XPS analysis, shown in Table 6, indicates an increase of nitrogen in the GO-MPD membrane, due to the cross-linking of amine groups in the cross-linker with GO, as well as partial reduction of oxygen as the epoxide was reduced.
Mechanical Strength Testing: The water flux of GO-based membrane coated on varies porous substrates is anticipated to be very high, or comparable with porous polysulfone substrate widely used in current reverse osmosis membranes.
To test the mechanical strength capability, the membranes are planned to be tested by placing them into a laboratory apparatus similar to the one shown in
From the data collected, it was shown that the GO-PVA-based membrane can withstand reverse osmosis pressures while providing sufficient flux.
Dehydration Characteristics—Water Vapor Permeability Testing:
The water vapor permeability of the membranes was tested. For the gas leakage, Nitrogen was chosen to mimic air.
A sample diagram of the setup is shown in
For the measurements, selected membranes were placed in the setup and the wet side inlet was set to a relative humidity of between about 80% to about 90%. The dry side inlet had a relative humidity of 0%. The upstream pressure for the wet gas stream was set to 0.13 psig. The upstream pressure for the dry gas stream was set to 0.03 psi g. From the instruments, the water vapor pressure and absolute humidity at the three measurement stations (input and output on the wet N2 gas side, and output on the dry N2 gas side) was derived by using the measured temperature and humidity. Then the water vapor transmission rate was derived from the absolute humidity difference, flow rate, and exposed area of the membrane. Lastly the water vapor permeability was derived from the water vapor transmission rate and the water vapor pressure difference between the two plenums. The nitrogen flow rate was derived from the dry N2 output and the wet N2 inputs as well as the water vapor transmission rate.
Dehydration Characteristics—Nitrogen Leakage Testing:
The gas leakage of the membranes was tested. For the gas leakage, Nitrogen was chosen to mimic air. For these tests, the same test setup was used as in the Water Vapor Permeability testing with the exception that the dry N2 air inlet was closed and the dry N2 outlet was, instead of being vented to atmosphere, was vented to a flow measurement instrument (D800286 Gilibrator-2 Standard Air Flow Calibrator; Sensidyne, St. Petersburg, Fla., USA) with a normal test cell (20 cc to 6 LPM, Sensidyne) or a low-flow test cell (1 cc/min to 250 cc/min, Sensidyne) to measure the flow leakage through the membrane. For N2 flow rates at about 1 cc/min or below, a 0.5 mL manual bubble flow meter was used (#23771, Aldrich), which has a range of about 0.03 cc/min to about 5 cc/min, to determine the leakage rate instead of the aforementioned flow measurement instrument.
For the measurements, the selected membranes were placed in the setup and the wet side inlet was set to a relative humidity of between about 80% to about 90%. The dry side inlet was closed to seal off the portion upstream of the flow measurement instrument so that only gas leaked through the membrane would go to the flow measurement instrument. The upstream pressure for the wet gas stream was set to 0.13 psig and the leakage of the N2 through the membrane was measured.
Water Flux and Salt Rejection Testing:
The water flux of GO-based membrane coating on a porous substrate was observed to be very high, which is comparable with porous polysulfone substrate widely use in current reverse osmosis membranes.
To test the salt rejection capability, the reverse osmosis membranes were tested in a test cell similar to that disclosed in
61
2,0531
1Membrane data appeared unreliable; possibly due to a larger than normal membrane defect.
Unless otherwise indicated, all numbers expressing quantities of ingredients, properties such as molecular weight, reaction conditions, and etc. used in herein are to be understood as being modified in all instances by the term “about.” Each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Accordingly, unless indicated to the contrary, the numerical parameters may be modified according to the desired properties sought to be achieved, and should, therefore, be considered as part of the disclosure. At the very least, the examples shown herein are for illustration only, not as an attempt to limit the scope of the disclosure.
The terms “a,” “an,” “the” and similar referents used in the context of describing embodiments of the present disclosure (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. All methods described herein may be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illustrate embodiments of the present disclosure and does not pose a limitation on the scope of any claim. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the embodiments of the present disclosure.
Groupings of alternative elements or embodiments disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability.
Certain embodiments are described herein, including the best mode known to the inventors for carrying out the embodiments. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the embodiments of the present disclosure to be practiced otherwise than specifically described herein. Accordingly, the claims include all modifications and equivalents of the subject matter recited in the claims as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is contemplated unless otherwise indicated herein or otherwise clearly contradicted by context.
In closing, it is to be understood that the embodiments disclosed herein are illustrative of the principles of the claims. Other modifications that may be employed are within the scope of the claims. Thus, by way of example, but not of limitation, alternative embodiments may be utilized in accordance with the teachings herein. Accordingly, the claims are not limited to embodiments precisely as shown and described.
This application claims the benefit of U.S. provisional application 62/465,635, filed Mar. 1, 2017, which is incorporated by reference by its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2018/020505 | 3/1/2018 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62465635 | Mar 2017 | US |
